Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)

This study is looking at whether certain blood markers — high-sensitivity cardiac troponin I, NT-proBNP, and ST2 — can predict the risk of heart problems or death in people with type 2 diabetes. These are proteins that may signal stress or damage to the heart. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - You attend outpatient clinic visits for your diabetes care **You may NOT be eligible if...** - You have type 1 diabetes - You have active cancer or are in cancer remission for less than 5 years - Your doctor determines you are not a suitable candidate for the study for medical or other reasons Talk to your doctor to see if this trial is right for you.